Literature DB >> 10737899

p53/56(lyn) antisense shifts the 1,25-dihydroxyvitamin D3-induced G1/S block in HL60 cells to S phase.

Q M Wang1, G P Studzinski, F Chen, F D Coffman, L E Harrison.   

Abstract

p53/56(lyn) is a member of the src family that is predominantly expressed in hematopoietic cells and is thought to play a role in cellular proliferation. In this study, we demonstrate the participation of p53/56(lyn) in 1,25-dihydroxyvitamin D(3) (1, 25D(3))-induced growth arrest in HL60 cells. We show that the mRNA and protein levels of p53/56(lyn) are markedly elevated after 1, 25D(3) treatment, which is accompanied by an increase of p53/56(lyn) kinase activity. We also demonstrate that treatment with p53/56(lyn) antisense oligodeoxynucleotides reverses the 1,25D(3)-induced G1/S block, and results in an accumulation of cells with S-phase DNA content. BrdU pulse-chase experiments reveal that this accumulation results from an increased proportion of cells actively synthesizing DNA, which are inhibited from exiting the S-phase compartment. These results indicate that upregulation of p53/56(lyn) contributes significantly to the G1/S growth arrest induced by 1,25D(3) in HL60 cells and thus its activation may be a desirable outcome of chemotherapeutic regimens. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10737899     DOI: 10.1002/(SICI)1097-4652(200005)183:2<238::AID-JCP10>3.0.CO;2-1

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

Review 1.  Vitamin D and differentiation in cancer.

Authors:  Elzbieta Gocek; George P Studzinski
Journal:  Crit Rev Clin Lab Sci       Date:  2009       Impact factor: 6.250

Review 2.  New insights into vitamin D anticancer properties: focus on miRNA modulation.

Authors:  Katarina Zeljic; Gordana Supic; Zvonko Magic
Journal:  Mol Genet Genomics       Date:  2017-02-27       Impact factor: 3.291

3.  Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia.

Authors:  Eric I Zimmerman; Claudia M Dollins; Melissa Crawford; Steven Grant; Serge P Nana-Sinkam; Kristy L Richards; Scott M Hammond; Lee M Graves
Journal:  Mol Pharmacol       Date:  2010-08-06       Impact factor: 4.436

4.  Increased neurogenesis in adult mCD24-deficient mice.

Authors:  Richard Belvindrah; Geneviève Rougon; Geneviève Chazal
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

5.  MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3.

Authors:  Xuening Wang; Elzbieta Gocek; Chang-Gong Liu; George P Studzinski
Journal:  Cell Cycle       Date:  2009-03-18       Impact factor: 4.534

6.  Regulation of Leukemic Cell Differentiation through the Vitamin D Receptor at the Levels of Intracellular Signal Transduction, Gene Transcription, and Protein Trafficking and Stability.

Authors:  Elżbieta Gocek; Hanna Baurska; Aleksandra Marchwicka; Ewa Marcinkowska
Journal:  Leuk Res Treatment       Date:  2012-05-14

Review 7.  The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia Therapy.

Authors:  Elzbieta Gocek; George P Studzinski
Journal:  J Clin Med       Date:  2015-03-25       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.